NASDAQ:IKT

Inhibikase Therapeutics, Inc.

Read IKT's Filings Free

Company facts

Most recent report
8-K, filed Sep 8, 2026
Incorporated
Delaware
Filings on record
365 filings
On EDGAR
CIK 1750149
Fiscal year ends
December
Filer status
Non-accelerated filer, Smaller reporting company

Financials 8 of 25

News 8 of 69

Prospectuses and Registrations 8 of 39

Proxies 8 of 24

Ownership 8 of 150

Other 8 of 58

Everything here comes from Inhibikase Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.